US Food and Drug Administration
Additionally, factors secreted by retinal cells, like IL-6, promote the proliferation of different retinal cell types, contributing to the formation of new blood vessels and the progression of diabetic retinopathy (84)
This product is sold strictly for in-vitro research and laboratory use only
It may be prescribed off-label for weight management in a licensed healthcare provider's sole clinical judgment
1 As effectiveness of newer dosage forms continues to build, awareness of these drugs rises further (driven by awareness building campaigns) and lower out of pocket costs drive price elasticity, 2 our estimates suggest 1 in 2 eligible adults may adopt a GLP-1 drug over the next 10 year
Liraglutide was the first GLP-1 receptor analogue approved for the management of obesity, thus starting the new era of gastrointestinal peptide agonist pharmacotherapy for the treatment of both diabetes and obesity